NYSE · Financial Statements

Becton, Dickinson and Company (BDX) Revenue, Earnings & Financial Statements

$215.42 NYSE: BDX Market Cap $58.68B

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Becton, Dickinson and Company most recently reported annual revenue of $19.5B, net profit of $1.1B. Revenue grew at an average annual rate of 0.3% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Becton, Dickinson and Company: Revenue rose from $12.1B in 2017 to $19.5B in 2026, a change of +60.9% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 12.6% to 11.6%, a shift of -1.0 percentage points; the most recent year shows net profit of $1.1B.

Income Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Revenue$12.1B$16.0B$17.3B$16.1B$19.1B$18.9B$19.4B$20.2B$21.8B$19.5B
Operating Expenses$10.6B$14.5B$15.5B$15.2B$16.9B$16.6B$17.3B$17.8B$19.3B$17.2B
Operating Profit$1.5B$1.5B$1.8B$912.0M$2.3B$2.3B$2.1B$2.4B$2.6B$2.3B
Operating Margin12.6%9.4%10.2%5.7%11.8%12.1%10.9%11.9%11.8%11.6%
Other Income−$546.0M−$336.0M−$584.0M−$498.0M−$558.0M−$499.0M−$449.0M−$392.0M−$696.0M−$451.0M
Interest$521.0M$706.0M$639.0M$528.0M$469.0M$398.0M$452.0M$528.0M$613.0M$564.0M
Depreciation$1.1B$2.0B$2.3B$2.1B$2.2B$2.2B$2.3B$2.3B$2.5B$2.2B
Profit Before Tax$976.0M$1.2B$1.2B$414.0M$1.7B$1.8B$1.7B$2.0B$1.9B$1.8B
Tax rate (%)-12.7%73.5%-4.8%15.0%5.2%8.3%7.9%15.0%10.8%21.5%
Net Profit$1.1B$311.0M$1.2B$874.0M$2.1B$1.8B$1.5B$1.7B$1.7B$1.1B
EPS$4.60$0.60$3.89$2.71$6.85$5.88$4.94$5.86$5.83$4.09

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$4.7B$5.0B$5.0B$5.4B$5.2B$5.3B$5.5B$5.9B$5.3B$4.7B$5.0B$5.3B
Operating Expenses$4.3B$4.3B$4.4B$4.8B$4.7B$4.7B$4.6B$5.2B$4.7B$4.6B$4.3B$4.2B
Operating Profit$439.0M$734.0M$602.0M$622.0M$453.0M$546.0M$882.0M$697.0M$594.0M$94.0M$663.0M$1.0B
Operating Margin9.3%14.6%12.1%11.4%8.8%10.4%16.0%11.8%11.3%2.0%13.3%19.6%
Interest$111.0M$125.0M$137.0M$155.0M$155.0M$151.0M$152.0M$155.0M$107.0M$149.0M$132.0M$130.0M
Profit Before Tax$359.0M$633.0M$500.0M$514.0M$306.0M$363.0M$703.0M$510.0M$487.0M$39.0M$554.0M$901.0M
Tax rate (%)21.4%15.2%2.6%22.2%1.0%15.2%18.4%3.3%21.6%194.9%18.6%23.2%
Net Profit$281.0M$537.0M$487.0M$400.0M$303.0M$308.0M$574.0M$493.0M$382.0M−$311.0M$377.0M$696.0M
EPS$0.96$1.85$1.68$1.45$1.04$1.07$2.00$1.72$1.34−$1.11$1.37$2.54

Over the 10 years reported for Becton, Dickinson and Company, borrowings decreased from $18.9B in 2017 to $16.3B in 2026, cash stood at $725.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 0.87 times.

Balance Sheet — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Total Assets$37.7B$53.9B$51.8B$54.0B$53.9B$52.9B$52.8B$57.3B$55.3B$50.8B
Current Assets$18.6B$7.4B$6.6B$9.0B$8.8B$8.1B$8.7B$10.5B$9.3B$8.3B
Cash$14.2B$1.1B$536.0M$2.8B$2.4B$1.2B$1.4B$1.9B$851.0M$725.0M
Inventory$1.8B$2.5B$2.6B$2.7B$2.7B$3.2B$3.3B$3.8B$3.9B$3.2B
Receivables$1.7B$2.3B$2.3B$2.4B$2.4B$2.2B$2.5B$3.0B$3.0B$2.8B
Fixed Assets$4.6B$5.4B$5.7B$5.9B$6.0B$6.0B$6.6B$6.8B$7.0B$6.2B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$75.0M$17.0M$30.0M$20.0M$12.0M$8.0M$8.0M$445.0M$8.0M$8.0M
Other Assets$7.6B$23.6B$23.4B$23.6B$23.9B$24.6B$24.5B$26.5B$33.0B$33.6B
Total Liabilities$24.8B$32.9B$30.7B$30.2B$30.2B$27.7B$27.0B$31.4B$29.9B$26.1B
Current Liabilities$3.3B$7.2B$5.7B$5.8B$6.6B$7.8B$6.6B$9.0B$8.3B$9.5B
Borrowings$18.9B$21.5B$19.4B$17.9B$18.4B$17.0B$16.8B$21.6B$19.2B$16.3B
Other Liabilities$5.9B$11.4B$11.3B$12.3B$11.8B$10.7B$10.2B$9.8B$10.8B$9.8B
Equity$347.0M$347.0M$347.0M$365.0M$365.0M$365.0M$371.0M$371.0M$371.0M$0
Reserves$12.9B$21.0B$21.1B$23.8B$23.7B$25.3B$25.8B$25.9B$25.4B$24.7B

For Becton, Dickinson and Company, operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $2.9B; free cash flow was positive in 10 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Operating Cash Flow$2.5B$2.9B$3.3B$3.5B$4.6B$2.6B$3.0B$3.8B$3.4B$3.6B
Investing Cash Flow−$1.6B−$16.7B−$1.7B−$2.0B−$3.1B−$4.2B−$1.6B−$6.2B−$1.6B−$1.7B
Financing Cash Flow−$454.0M−$220.0M−$204.0M−$109.0M−$2.0B$569.0M−$121.0M−$588.0M−$1.1B$1.4B
Net Cash Flow$12.6B−$13.0B−$646.0M$2.3B−$525.0M−$1.2B$322.0M$375.0M−$1.0B$233.0M
Free Cash Flow$1.8B$2.0B$2.4B$2.7B$3.4B$1.7B$2.1B$3.1B$2.7B$2.9B

Valuation & Return Ratios

MetricValue
PEG Ratio-1.76
EV / EBITDA15.02
FCF Yield4.88%
Quick Ratio5.43
Interest Coverage4.60
Return 1Y46.88%
Return 3Y24.77%
Return 5Y23.06%

Becton, Dickinson and Company (BDX) financials — frequently asked questions

What is Becton, Dickinson and Company's annual revenue?

Becton, Dickinson and Company (BDX) reported annual revenue of $19.5B in its most recent fiscal year.

What is Becton, Dickinson and Company's net profit?

Becton, Dickinson and Company (BDX) reported net profit of $1.1B in its most recent fiscal year.

What is BDX EV/EBITDA?

Becton, Dickinson and Company's enterprise value to EBITDA (EV/EBITDA) ratio is 15.02.

Revenue and earnings of other Medical - Instruments & Supplies stocks

MDLN stockWST revenue $3.1BSOLV revenue $8.3BBAX revenue $11.2BCOO revenue $4.1BRGEN revenue $738.0MAVTR revenue $6.6BATR revenue $3.8BBLCO revenue $5.1BTFX revenue $2.0BAll Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
BDX Overview BDX Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.